The discovery of antibiotics has always been a medical advance that has improved the prognosis of infections. However, resistance to these products has evolved into a major health problem. Some diseases are even resistant to all antibiotics currently available on the market. A reduction in the use of antibiotics must be based on other approaches, namely the use of alternative treatments to antibiotics, such as phytotherapy. In the same objective our study focused on the research of the antibacterial power of Olea Europaea known for its various medicinal properties. 31 bacterial strains were tested for their susceptibility using the agar diffusion method, and we determined their MIC by the micro titration technique on microplates. Five bacteria belonged to the American collection (ATCC) and 26 strains isolated from nosocomial infections between the period of 2011 and 2015. We noticed that our aqueous, methanolic, ethanolic and ethyl acetate extracts are active against all tested bacteria. On the other hand, we observed that the hexane and dichloromethane extracts showed no inhibition effect on all the bacteria tested. The methanolic extract showed a higher MIC against ESBL enterobacteria (E. coli, E. cloacae, P. mirabilis) and imipenem-resistant A. baumanii. The lowest MIC was 1.56 ug / ml.
Nosocomial infections are a major public health problem. They are mainly caused by bacteria that often present antibiotic resistance profiles, which complicates their management. The diagnosis of these infections is based on clinical and biological criteria that lack sensitivity and specificity, and on microbiological examinations that are lengthy. Unfortunately, the inadequate empirical antibiotic therapy in many cases, and the late implementation of an effective treatment, are associated with the emergence and spread of bacteria that are multi-resistant to antibiotics, i.e. strains producing extended-spectrum beta-lactamases (ESBL). Rapid diagnostic methods, identifying the pathogen and its resistance profile, are therefore necessary. Our laboratory is committed to develop PCR techniques to genotypically identify the most frequent ESBLs from four hospital facilities. Among all the enterobacteria detected, we observed the predominance of OXA type ESBL (38%), followed by CTX-M type ESBL (33%). TEM and SHV genes represent respectively 19% and 10%.The optimization of these technologies could allow the identification of all known resistance mechanisms in only a few hours and find new preventive or curative strategies in the fight against these nosocomial infections, to better respond to this health threat.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.